申请人:Kaken Pharmaceutical Co., Ltd.
公开号:US05276041A1
公开(公告)日:1994-01-04
An oxime derivative of the formula: ##STR1## wherein R is a hydrogen atom or a C.sub.1-5 alkyl group, R.sub.1 is a hydrogen atom, a C.sub.1-5 alkyl group or a carboxyl-protecting group, R.sub.2 is a hydrogen atom, a halogen atom, a hydroxyl group or an amino group, R.sub.3 is a C.sub.3-7 cycloalkyl group, R.sub.4 is a hydrogen atom, a halogen atom or a C.sub.1-4 alkoxy group, each of R.sub.5 and R.sub.6 which may be the same or different, is a hydrogen atom or a C.sub.1-5 alkyl group, or R.sub.5 and R.sub.6 together represent a C.sub.2-4 alkylene group which forms together with the adjacent carbon atom a C.sub.3-5 ring, provided that when R.sub.2 is a hydrogen atom, R.sub.4 is a C.sub.1-4 alkoxy group, m is an integer of 0 or 1, and n is an integer of from 1 to 3; or its pharmaceutically acceptable salt.
一种公式为:##STR1##的肟衍生物,其中R是氢原子或C.sub.1-5烷基基团,R.sub.1是氢原子、C.sub.1-5烷基基团或羧基保护基团,R.sub.2是氢原子、卤素原子、羟基或氨基,R.sub.3是C.sub.3-7环烷基基团,R.sub.4是氢原子、卤素原子或C.sub.1-4烷氧基团,R.sub.5和R.sub.6中的每一个可能相同或不同,是氢原子或C.sub.1-5烷基基团,或者R.sub.5和R.sub.6一起表示一个C.sub.2-4烷基基团,与相邻的碳原子一起形成一个C.sub.3-5环,前提是当R.sub.2是氢原子时,R.sub.4是C.sub.1-4烷氧基团,m是0或1的整数,n是1到3的整数;或其药学上可接受的盐。